Jim Kastenmayer

Jim Kastenmayer

Consejero General en ARRIVENT BIOPHARMA, INC. .

Fortuna: 221 949 $ al 31/08/2026

54 años
Health Technology
Consumer Services

Perfil

James Kastenmayer currently works at Arrivent BioPharma, Inc., as Secretary & General Counsel.
Dr. Kastenmayer also formerly worked at AstraZeneca PLC, as Legal Director & Senior Patent Director from 2012 to 2019, Spyre Therapeutics, Inc., as Secretary & General Counsel from 2022 to 2023, MedImmune LLC, as IP Counsel, and Viela Bio, Inc., as Secretary, General Counsel & Senior Vice President from 2020 to 2021.
Dr. Kastenmayer received his doctorate degree from Michigan State University, undergraduate degree from the University of Virginia, and graduate degree from Georgetown University Law Center.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
02/02/2026 7.386 ( 0,02 % ) 221 949 $ 31/08/2026

Cargos activos de Jim Kastenmayer

EmpresasCargoInicio
ARRIVENT BIOPHARMA, INC. Consejero General 01/09/2023

Antiguos cargos conocidos de Jim Kastenmayer.

EmpresasCargoFin
SPYRE THERAPEUTICS, INC. Director Ejecutivo 29/11/2022
VIELA BIO, INC. Consejero General 01/03/2021
ASTRAZENECA PLC Consejero General 01/12/2019
Corporate Officer/Principal -
Ver el detalle de la experiencia de Jim Kastenmayer.

Formación de Jim Kastenmayer.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

68

Relaciones de 1er grado

8

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas8

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

ÚLTIMAS HORA | -40%. Las herramientas más útiles solo para suscriptores: ¡descubre las mejores inversiones del futuro!
d
:
:
APROVECHAR LA PROMOCIÓN